Mirae Asset Global Investments Co. Ltd. raised its stake in PetMed Express, Inc. (NASDAQ:PETS – Get Rating) by 4.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 589,467 shares of the company’s stock after acquiring an additional 24,763 shares during the quarter. Mirae Asset Global Investments Co. Ltd. owned approximately 2.80% of PetMed Express worth $10,434,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in PETS. Millennium Management LLC purchased a new position in PetMed Express in the second quarter valued at about $4,994,000. UBS Group AG raised its position in shares of PetMed Express by 779.2% in the fourth quarter. UBS Group AG now owns 267,173 shares of the company’s stock valued at $4,729,000 after purchasing an additional 236,786 shares during the period. SG Americas Securities LLC raised its position in shares of PetMed Express by 3,082.4% in the fourth quarter. SG Americas Securities LLC now owns 193,297 shares of the company’s stock valued at $3,421,000 after purchasing an additional 187,223 shares during the period. Cubist Systematic Strategies LLC raised its position in shares of PetMed Express by 1,323.8% in the second quarter. Cubist Systematic Strategies LLC now owns 176,870 shares of the company’s stock valued at $3,520,000 after purchasing an additional 164,448 shares during the period. Finally, Renaissance Technologies LLC raised its position in shares of PetMed Express by 19.1% in the first quarter. Renaissance Technologies LLC now owns 972,784 shares of the company’s stock valued at $25,098,000 after purchasing an additional 156,300 shares during the period. 77.74% of the stock is currently owned by hedge funds and other institutional investors.
PetMed Express Stock Down 4.9 %
NASDAQ PETS opened at $14.72 on Friday. The company’s 50 day moving average is $15.80 and its 200-day moving average is $18.15. PetMed Express, Inc. has a 12-month low of $14.44 and a 12-month high of $24.01. The firm has a market cap of $310.30 million, a P/E ratio of 25.83 and a beta of 0.64.
Analysts Set New Price Targets
About PetMed Express
PetMed Express, Inc engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. Its non-prescription medications include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies.
- Get a free copy of the StockNews.com research report on PetMed Express (PETS)
- MarketBeat Week in Review – 5/15 – 5/19
- Applied Materials: Cracks In The Chip Recovery Or Time To Buy?
- Deere & Company Rallies On Farm Equipment Boom, Bullish Outlook
- How Many Roth IRAs Can You Have?
- Why You Should Consider Buying Nvidia Ahead Of Earnings
Want to see what other hedge funds are holding PETS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PetMed Express, Inc. (NASDAQ:PETS – Get Rating).
Receive News & Ratings for PetMed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express and related companies with MarketBeat.com's FREE daily email newsletter.